rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AXGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      AxoGen: 3 Key Takeaways for Long-Term Investors
      Nov 16Yahoo FinanceAXGN
      Axogen (AXGN) Stock Could Be 22% Overvalued On Cash Flow Expectations

      Axogen has delivered a very large 3 year return, which puts a bright spotlight on what investors are really paying for in terms of future cash generation. With the share price recently closing at US$58.63, the question now is how that move lines up with the cash flows the business may realistically produce over time. The stock has returned roughly 9x over the past 3 years, which makes the link between Axogen's current valuation and its cash flow profile especially important for anyone...

      Nov 12Yahoo FinanceAXGN
      Axogen stock hits 52-week high at $52.92
      Nov 11Investing.comAXGN
      AxoGen at Canaccord forum: growth plan widens beyond nerve repair
      Nov 11Investing.comAXGN
      Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
      Nov 3Yahoo FinanceAXGN
      Axogen: Taking The Friction Out Of Nerve Repair (NASDAQ:AXGN)

      Axogen (AXGN) is evolving from a growth story to the default procedural platform in peripheral nerve repair, protected by a regulatory moat for the next...

      Oct 30Seeking AlphaAXGN
      Is AxoGen (AXGN) Outperforming Other Medical Stocks This Year?

      Here is how AxoGen (AXGN) and BioCryst Pharmaceuticals (BCRX) have performed compared to their sector so far this year.

      Oct 29Yahoo FinanceAXGN
      Truist Securities Adjusts Price Target on Axogen to $60 From $53, Keeps Buy Rating
      Oct 29Yahoo FinanceAXGN
      Axogen Inc (AXGN) (Q3 2026) Earnings Call Highlights: Revenue Jumps 26% as Breast Market Surges ...
      Oct 29Yahoo FinanceAXGN
      Raymond James raises AxoGen stock price target on revenue growth
      Oct 29Investing.comAXGN
      Does Axogen (AXGN) Have More Upside Or Is It Fully Priced?
      Oct 28Yahoo FinanceAXGN
      AxoGen Q3 Earnings Call Highlights
      Oct 28Yahoo FinanceAXGN
      AxoGen, Inc. Q3 2026 Earnings Call Summary
      Oct 28Yahoo FinanceAXGN
      Mizuho raises AxoGen stock price target to $65 on growth outlook
      Oct 28Investing.comAXGN
      Axogen (AXGN) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Oct 28The Globe and MailAXGN
      AxoGen: Q3 Earnings Snapshot
      Oct 28Yahoo FinanceAXGN
      AxoGen Q3 2026 slides: revenue surges 26%, breast growth accelerates
      Oct 28Investing.comAXGN
      Axogen Soars 29% on Q3 Beat, Lifts 2026 Revenue Guidance to at Least $290 Million
      Oct 28Yahoo FinanceAXGN
      Why is Axogen stock surging today?
      Oct 28Investing.comAXGN
      Axogen Q3 Adjusted Net Income, Revenue Increase; 2026 Revenue Guidance Lifted; Shares Rise
      Oct 28Yahoo FinanceAXGN
      Earnings call transcript: AxoGen beats Q3 2026 estimates and lifts outlook
      Oct 28Investing.comAXGN
      Axogen Q3 2026 Earnings Call Transcript
      Oct 28BenzingaAXGN
      Axogen Inc earnings beat by $0.08, revenue topped estimates
      Oct 28Investing.comAXGN
      12 Health Care Stocks Moving In Wednesday's Pre-Market Session
      Oct 28BenzingaAXGN
      AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates
      Oct 28Yahoo FinanceAXGN
      Axogen, Inc. Reports Third Quarter 2026 Financial Results
      Oct 28Yahoo FinanceAXGN
      Axogen earnings up next: Can nerve repair leader return to profit?
      Oct 27Investing.comAXGN
      AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth
      Oct 21Yahoo FinanceAXGN
      Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
      Oct 14Yahoo FinanceAXGN
      AxoGen stock initiated at Buy by BofA on growth outlook
      Oct 12Investing.comAXGN
      BofA Securities Initiates Axogen at Buy, $52 Price Target
      Oct 12Yahoo FinanceAXGN
      Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target
      Oct 7Yahoo FinanceAXGN
      Barclays Initiates Axogen at Overweight With $55 Price Target
      Oct 7Yahoo FinanceAXGN
      Wells Fargo Sticks to Its Buy Rating for AxoGen (AXGN)

      Detailed price information for Axogen Inc (AXGN-Q) from The Globe and Mail including charting and trades.

      Oct 4The Globe and MailAXGN
      Axogen completes acquisition of BioCircuit Technologies
      Oct 1Investing.comAXGN
      Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)

      Detailed price information for Biohaven Ltd (BHVN-N) from The Globe and Mail including charting and trades.

      Oct 1The Globe and MailALNYAXGN
      Truist cuts AxoGen stock price target to $53 on dilution concerns
      Oct 1Investing.comAXGN
      Truist Cuts Price Target on Axogen to $53 From $60, Keeps Buy Rating

      Axogen (AXGN) has an average rating of buy and mean price target of $53.70, according to analysts po

      Oct 1Yahoo FinanceAXGN
      Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
      Oct 1Yahoo FinanceAXGN
      Jefferies Reaffirms Their Buy Rating on AxoGen (AXGN)

      Detailed price information for Axogen Inc (AXGN-Q) from The Globe and Mail including charting and trades.

      Sep 30The Globe and MailAXGN
      Truist reiterates Buy on AxoGen stock after Aetna coverage win
      Sep 29Investing.comAXGN
      Raymond James raises AxoGen stock price target on growth outlook
      Sep 25Investing.comAXGN
      10 Health Care Stocks Whale Activity In Today’s Session - Axogen (NASDAQ:AXGN), Hims & Hers Health (NYSE:

      This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

      Sep 24BenzingaAXGN
      Jefferies Remains a Buy on AxoGen (AXGN)

      Detailed price information for Axogen Inc (AXGN-Q) from The Globe and Mail including charting and trades.

      Sep 16The Globe and MailAXGN
      Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Definium Therapeutics (DFTX)

      Tipranks Press Release.

      Sep 15The Globe and MailAXGN
      Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and BioMarin Pharmaceutical (BMRN)

      Detailed price information for Biomarin Pharmaceuticals (BMRN-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailAXGN
      Axogen deepens nerve repair portfolio through $200m BioCircuit takeover

      Through its BioCircuit buyout, Axogen hopes to extend the market uptake of the former’s NerveTape, a sutureless peripheral nerve repair device.

      Sep 11Yahoo FinanceAXGN
      Why Is Axogen Stock Tumbling Today? - Axogen (NASDAQ:AXGN)
      Sep 10BenzingaAXGN
      Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair

      Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash.The strategic acquisition integrates NerveTape, the first FDA-approved sutureless nerve repair device, into Axogen’s existing surgical solutions for restoring peripheral nerve function.Funding The AcquisitionTo finance the $200 million purchase price, Axogen launched an underwritten public offering of 4.91 million shares of common stock, pri

      Sep 10Yahoo FinanceAXGN
      Axogen stock falls as $208.7M offering dilutes shareholders
      Sep 10Investing.comAXGN

      This is the newest page. Registered accounts read further back.